STOCK FOCUS
Bumrungrad Hospital Plc

Tisco Securities has maintained a "buy" rating on Bumrungrad Hospital stocks, with an increased share price target of Bt41.50 for the next year.
Bumrungrad Hospital continues to lead the private healthcare industry in Thailand with a growing international reputation for providing high-quality services, including state-of-the-art medical technology. The broker said strong pricing power, rising demand for its services and expansion both at home and abroad should continue to underpin its earnings growth. The company's new 22-storey out-patient building is scheduled to begin commercial operations in the middle of the fourth quarter. It will lift out-patient capacity 57 per cent to 5,500 patient visits a day. Its existing out-patient department will be converted into space for in-patients, with another 40 beds to be added each year over the next three years. The broker has maintained its net-profit forecasts of Bt1.14 billion this year and Bt1.41 billion next year. Bumrungrad's first-half revenues grew 19 per cent on year to Bt3.78 billion, driven primarily by revenues from foreign patients, which increased 2.3 times faster than revenues from Thai patients.
|